149 related articles for article (PubMed ID: 22648150)
21. The effect of water solubility of solutes on their flux through human skin in vitro: a prodrug database integrated into the extended Flynn database.
Juntunen J; Majumdar S; Sloan KB
Int J Pharm; 2008 Mar; 351(1-2):92-103. PubMed ID: 18023303
[TBL] [Abstract][Full Text] [Related]
22. N-Mannich-base prodrugs of 5-iodo-2'-deoxycytidine as topical delivery enhancers.
Koch SA; Sloan KB
Pharm Res; 1987 Aug; 4(4):317-20. PubMed ID: 3508538
[TBL] [Abstract][Full Text] [Related]
23. Transdermal delivery of atenolol: effect of prodrugs and iontophoresis.
Anroop B; Ghosh B; Parcha V; Khanam J
Curr Drug Deliv; 2009 Jul; 6(3):280-90. PubMed ID: 19604142
[TBL] [Abstract][Full Text] [Related]
24. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: S6-acyloxymethyl-6-mercaptopurine prodrugs.
Waranis RP; Sloan KB
J Pharm Sci; 1988 Mar; 77(3):210-5. PubMed ID: 3373424
[TBL] [Abstract][Full Text] [Related]
25. Impact of ester promoieties on transdermal delivery of ketorolac.
Liu KS; Hsieh PW; Aljuffali IA; Lin YK; Chang SH; Wang JJ; Fang JY
J Pharm Sci; 2014 Mar; 103(3):974-86. PubMed ID: 24481782
[TBL] [Abstract][Full Text] [Related]
26. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs.
Waranis RP; Sloan KB
J Pharm Sci; 1987 Aug; 76(8):587-95. PubMed ID: 11002816
[TBL] [Abstract][Full Text] [Related]
27. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability.
Chen Y; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():103-13. PubMed ID: 26686649
[TBL] [Abstract][Full Text] [Related]
28. The effect of lipid and aqueous solubilities on flux of nicotinic acid esters from water through silicone membrane.
Synovec J; Wasdo SC; Sloan KB
Drug Dev Ind Pharm; 2013 Sep; 39(9):1494-7. PubMed ID: 22676485
[TBL] [Abstract][Full Text] [Related]
29. Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone.
Vaddi HK; Hamad MO; Chen J; Banks SL; Crooks PA; Stinchcomb AL
Pharm Res; 2005 May; 22(5):758-65. PubMed ID: 15906171
[TBL] [Abstract][Full Text] [Related]
30. Transdermal delivery and cutaneous targeting of antivirals using a penetration enhancer and lysolipid prodrugs.
Diblíková D; Kopečná M; Školová B; Krečmerová M; Roh J; Hrabálek A; Vávrová K
Pharm Res; 2014 Apr; 31(4):1071-81. PubMed ID: 24271238
[TBL] [Abstract][Full Text] [Related]
31. Transdermal delivery of nalbuphine and its prodrugs by electroporation.
Sung KC; Fang JY; Wang JJ; Hu OY
Eur J Pharm Sci; 2003 Jan; 18(1):63-70. PubMed ID: 12554074
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of transdermal apomorphine delivery with a diester prodrug strategy.
Liu KS; Sung KC; Al-Suwayeh SA; Ku MC; Chu CC; Wang JJ; Fang JY
Eur J Pharm Biopharm; 2011 Aug; 78(3):422-31. PubMed ID: 21315820
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery.
Doh HJ; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
J Pharm Sci; 2003 May; 92(5):1008-17. PubMed ID: 12712420
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption.
Moss GP; Gullick DR; Cox PA; Alexander C; Ingram MJ; Smart JD; Pugh WJ
J Pharm Pharmacol; 2006 Feb; 58(2):167-77. PubMed ID: 16451744
[TBL] [Abstract][Full Text] [Related]
35. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study.
Wang JJ; Sung KC; Huang JF; Yeh CH; Fang JY
J Pharm Pharmacol; 2007 Jul; 59(7):917-25. PubMed ID: 17637185
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, hydrolyses and dermal delivery of N-alkyl-N-alkyloxycarbonylaminomethyl (NANAOCAM) derivatives of phenol, imide and thiol containing drugs.
Majumdar S; Sloan KB
Bioorg Med Chem Lett; 2006 Jul; 16(13):3590-4. PubMed ID: 16616488
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery.
Eldridge JA; Milewski M; Stinchcomb AL; Crooks PA
Bioorg Med Chem Lett; 2014 Nov; 24(22):5212-5. PubMed ID: 25442314
[TBL] [Abstract][Full Text] [Related]
38. Transdermal delivery of 5-fluorouracil through skin of hairless mice and humans in vitro: a comparison of the effect of formulations and a prodrug.
Sherertz EF; Sloan KB; McTiernan RG
Arch Dermatol Res; 1990; 282(7):463-8. PubMed ID: 2078050
[TBL] [Abstract][Full Text] [Related]
39. Modeling of flux through silicone membranes from water.
Wasdo S; Juntunen J; Devarajan H; Murray T; Nickels D; Singh S; Shanks T; Ulmer K; Sloan KB
Eur J Pharm Sci; 2008 Aug; 34(4-5):321-32. PubMed ID: 18588972
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro.
N'da DD; Breytenbach JC
J Pharm Pharmacol; 2009 Jun; 61(6):721-31. PubMed ID: 19505362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
